[Retracted] Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy

Table 2

Comparison of disease control rate (%).

Groups	n	Partial remission	Stable disease	Progressive disease	Disease control rate
Conventional group	45	11	8	26	19 (42.23)
Study group	45	22	17	6	39 (86.67)
X^2	—	—	—	—	19.397
	—	—	—	—	<0.001